Skin rash by gefitinib is a sign of favorable outcomes for patients of advanced lung adenocarcinoma in Japanese patients

Skin rash is one of the notorious adverse events of gefitinib as well as other epidermal growth factor receptor tyrosine kinase inhibitors. The differences of response rate and frequency of adverse events between ethnic groups are well known. Some reports demonstrated the correlation between develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiura, Yasoo, Nemoto, Etsuo, Kawai, Osamu, Ohkubo, Yasuyuki, Fusegawa, Hisae, Kaseda, Shizuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569587/
https://www.ncbi.nlm.nih.gov/pubmed/23420789
http://dx.doi.org/10.1186/2193-1801-2-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569587/
https://www.ncbi.nlm.nih.gov/pubmed/23420789
http://dx.doi.org/10.1186/2193-1801-2-22

Ejemplares similares